nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPN4—retina—type 2 diabetes mellitus	0.0143	0.0758	CbGeAlD
Alendronate—PTPN4—nephron tubule—type 2 diabetes mellitus	0.0135	0.0714	CbGeAlD
Alendronate—PTPRE—cardiovascular system—type 2 diabetes mellitus	0.0128	0.0674	CbGeAlD
Alendronate—PTPN4—cortex of kidney—type 2 diabetes mellitus	0.0116	0.0611	CbGeAlD
Alendronate—PTPRE—adipose tissue—type 2 diabetes mellitus	0.0112	0.0594	CbGeAlD
Alendronate—PTPN4—adipose tissue—type 2 diabetes mellitus	0.0107	0.0565	CbGeAlD
Alendronate—PTPRS—adipose tissue—type 2 diabetes mellitus	0.00917	0.0485	CbGeAlD
Alendronate—ATP6V1A—islet of Langerhans—type 2 diabetes mellitus	0.00829	0.0438	CbGeAlD
Alendronate—PTPRE—liver—type 2 diabetes mellitus	0.00789	0.0417	CbGeAlD
Alendronate—PTPN4—liver—type 2 diabetes mellitus	0.0075	0.0396	CbGeAlD
Alendronate—ATP6V1A—retina—type 2 diabetes mellitus	0.00709	0.0375	CbGeAlD
Alendronate—ATP6V1A—nephron tubule—type 2 diabetes mellitus	0.00668	0.0353	CbGeAlD
Alendronate—PTPRS—liver—type 2 diabetes mellitus	0.00643	0.034	CbGeAlD
Alendronate—FDPS—islet of Langerhans—type 2 diabetes mellitus	0.00625	0.033	CbGeAlD
Alendronate—ATP6V1A—kidney—type 2 diabetes mellitus	0.00587	0.031	CbGeAlD
Alendronate—ATP6V1A—pancreas—type 2 diabetes mellitus	0.00583	0.0308	CbGeAlD
Alendronate—ATP6V1A—cortex of kidney—type 2 diabetes mellitus	0.00571	0.0302	CbGeAlD
Alendronate—ATP6V1A—adipose tissue—type 2 diabetes mellitus	0.00529	0.0279	CbGeAlD
Alendronate—FDPS—nephron tubule—type 2 diabetes mellitus	0.00503	0.0266	CbGeAlD
Alendronate—FDPS—cardiovascular system—type 2 diabetes mellitus	0.00452	0.0239	CbGeAlD
Alendronate—FDPS—kidney—type 2 diabetes mellitus	0.00442	0.0234	CbGeAlD
Alendronate—FDPS—pancreas—type 2 diabetes mellitus	0.00439	0.0232	CbGeAlD
Alendronate—FDPS—cortex of kidney—type 2 diabetes mellitus	0.0043	0.0227	CbGeAlD
Alendronate—FDPS—adipose tissue—type 2 diabetes mellitus	0.00398	0.021	CbGeAlD
Alendronate—ATP6V1A—liver—type 2 diabetes mellitus	0.00371	0.0196	CbGeAlD
Alendronate—FDPS—liver—type 2 diabetes mellitus	0.00279	0.0148	CbGeAlD
Alendronate—Risedronate—PTGS2—type 2 diabetes mellitus	0.00165	0.396	CrCbGaD
Alendronate—Clodronate—PTGS2—type 2 diabetes mellitus	0.00147	0.353	CrCbGaD
Alendronate—Histamine Phosphate—CYP3A4—type 2 diabetes mellitus	0.00105	0.252	CrCbGaD
Alendronate—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000742	0.00135	CcSEcCtD
Alendronate—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000741	0.00135	CcSEcCtD
Alendronate—Angioedema—Orlistat—type 2 diabetes mellitus	0.000737	0.00134	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000736	0.00134	CcSEcCtD
Alendronate—Vertigo—Valsartan—type 2 diabetes mellitus	0.000734	0.00134	CcSEcCtD
Alendronate—Flatulence—Metformin—type 2 diabetes mellitus	0.000733	0.00133	CcSEcCtD
Alendronate—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000728	0.00133	CcSEcCtD
Alendronate—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000728	0.00133	CcSEcCtD
Alendronate—Malaise—Orlistat—type 2 diabetes mellitus	0.000728	0.00133	CcSEcCtD
Alendronate—Vertigo—Orlistat—type 2 diabetes mellitus	0.000725	0.00132	CcSEcCtD
Alendronate—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000723	0.00132	CcSEcCtD
Alendronate—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000722	0.00131	CcSEcCtD
Alendronate—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000722	0.00131	CcSEcCtD
Alendronate—Infection—Gliclazide—type 2 diabetes mellitus	0.000721	0.00131	CcSEcCtD
Alendronate—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00072	0.00131	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000719	0.00131	CcSEcCtD
Alendronate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000718	0.00131	CcSEcCtD
Alendronate—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000717	0.00131	CcSEcCtD
Alendronate—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000715	0.0013	CcSEcCtD
Alendronate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000712	0.0013	CcSEcCtD
Alendronate—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000711	0.0013	CcSEcCtD
Alendronate—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000706	0.00129	CcSEcCtD
Alendronate—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000703	0.00128	CcSEcCtD
Alendronate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000702	0.00128	CcSEcCtD
Alendronate—Erythema—Irbesartan—type 2 diabetes mellitus	0.000702	0.00128	CcSEcCtD
Alendronate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000701	0.00128	CcSEcCtD
Alendronate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000699	0.00127	CcSEcCtD
Alendronate—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000699	0.00127	CcSEcCtD
Alendronate—Chest pain—Valsartan—type 2 diabetes mellitus	0.000695	0.00127	CcSEcCtD
Alendronate—Myalgia—Valsartan—type 2 diabetes mellitus	0.000695	0.00127	CcSEcCtD
Alendronate—Dizziness—Glipizide—type 2 diabetes mellitus	0.000694	0.00126	CcSEcCtD
Alendronate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000693	0.00126	CcSEcCtD
Alendronate—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000692	0.00126	CcSEcCtD
Alendronate—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00069	0.00126	CcSEcCtD
Alendronate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000688	0.00125	CcSEcCtD
Alendronate—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000687	0.00125	CcSEcCtD
Alendronate—Chest pain—Orlistat—type 2 diabetes mellitus	0.000687	0.00125	CcSEcCtD
Alendronate—Myalgia—Orlistat—type 2 diabetes mellitus	0.000687	0.00125	CcSEcCtD
Alendronate—Discomfort—Orlistat—type 2 diabetes mellitus	0.000679	0.00124	CcSEcCtD
Alendronate—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000675	0.00123	CcSEcCtD
Alendronate—Malaise—Metformin—type 2 diabetes mellitus	0.000671	0.00122	CcSEcCtD
Alendronate—Alopecia—Losartan—type 2 diabetes mellitus	0.000671	0.00122	CcSEcCtD
Alendronate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00067	0.00122	CcSEcCtD
Alendronate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000668	0.00122	CcSEcCtD
Alendronate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000668	0.00122	CcSEcCtD
Alendronate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000666	0.00121	CcSEcCtD
Alendronate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000665	0.00121	CcSEcCtD
Alendronate—Infection—Valsartan—type 2 diabetes mellitus	0.000662	0.00121	CcSEcCtD
Alendronate—Rash—Glipizide—type 2 diabetes mellitus	0.000662	0.00121	CcSEcCtD
Alendronate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000661	0.0012	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000661	0.0012	CcSEcCtD
Alendronate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000661	0.0012	CcSEcCtD
Alendronate—Erythema—Losartan—type 2 diabetes mellitus	0.000661	0.0012	CcSEcCtD
Alendronate—Headache—Glipizide—type 2 diabetes mellitus	0.000658	0.0012	CcSEcCtD
Alendronate—Infection—Orlistat—type 2 diabetes mellitus	0.000654	0.00119	CcSEcCtD
Alendronate—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000651	0.00119	CcSEcCtD
Alendronate—Flatulence—Losartan—type 2 diabetes mellitus	0.000651	0.00119	CcSEcCtD
Alendronate—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000649	0.00118	CcSEcCtD
Alendronate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000648	0.00118	CcSEcCtD
Alendronate—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000647	0.00118	CcSEcCtD
Alendronate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000646	0.00118	CcSEcCtD
Alendronate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000642	0.00117	CcSEcCtD
Alendronate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000641	0.00117	CcSEcCtD
Alendronate—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000641	0.00117	CcSEcCtD
Alendronate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000639	0.00116	CcSEcCtD
Alendronate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000639	0.00116	CcSEcCtD
Alendronate—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000635	0.00116	CcSEcCtD
Alendronate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000634	0.00116	CcSEcCtD
Alendronate—Chest pain—Metformin—type 2 diabetes mellitus	0.000633	0.00115	CcSEcCtD
Alendronate—Myalgia—Metformin—type 2 diabetes mellitus	0.000633	0.00115	CcSEcCtD
Alendronate—Malaise—Irbesartan—type 2 diabetes mellitus	0.000633	0.00115	CcSEcCtD
Alendronate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000631	0.00115	CcSEcCtD
Alendronate—Headache—Pioglitazone—type 2 diabetes mellitus	0.00063	0.00115	CcSEcCtD
Alendronate—Discomfort—Metformin—type 2 diabetes mellitus	0.000626	0.00114	CcSEcCtD
Alendronate—Nausea—Glipizide—type 2 diabetes mellitus	0.000624	0.00114	CcSEcCtD
Alendronate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000623	0.00113	CcSEcCtD
Alendronate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000621	0.00113	CcSEcCtD
Alendronate—Pain—Gliclazide—type 2 diabetes mellitus	0.00062	0.00113	CcSEcCtD
Alendronate—Constipation—Gliclazide—type 2 diabetes mellitus	0.00062	0.00113	CcSEcCtD
Alendronate—Rash—Glimepiride—type 2 diabetes mellitus	0.000618	0.00113	CcSEcCtD
Alendronate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000617	0.00112	CcSEcCtD
Alendronate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000616	0.00112	CcSEcCtD
Alendronate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000615	0.00112	CcSEcCtD
Alendronate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000615	0.00112	CcSEcCtD
Alendronate—Headache—Glimepiride—type 2 diabetes mellitus	0.000614	0.00112	CcSEcCtD
Alendronate—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000613	0.00112	CcSEcCtD
Alendronate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000612	0.00111	CcSEcCtD
Alendronate—Anaemia—Losartan—type 2 diabetes mellitus	0.000611	0.00111	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000607	0.00111	CcSEcCtD
Alendronate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000605	0.0011	CcSEcCtD
Alendronate—Angioedema—Losartan—type 2 diabetes mellitus	0.000604	0.0011	CcSEcCtD
Alendronate—Infection—Metformin—type 2 diabetes mellitus	0.000603	0.0011	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.0006	0.00109	CcSEcCtD
Alendronate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000598	0.00109	CcSEcCtD
Alendronate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000598	0.00109	CcSEcCtD
Alendronate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000598	0.00109	CcSEcCtD
Alendronate—Malaise—Losartan—type 2 diabetes mellitus	0.000596	0.00108	CcSEcCtD
Alendronate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000595	0.00108	CcSEcCtD
Alendronate—Vertigo—Losartan—type 2 diabetes mellitus	0.000593	0.00108	CcSEcCtD
Alendronate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000593	0.00108	CcSEcCtD
Alendronate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00059	0.00108	CcSEcCtD
Alendronate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000587	0.00107	CcSEcCtD
Alendronate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000584	0.00106	CcSEcCtD
Alendronate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000582	0.00106	CcSEcCtD
Alendronate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00058	0.00106	CcSEcCtD
Alendronate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00058	0.00106	CcSEcCtD
Alendronate—Asthenia—Glyburide—type 2 diabetes mellitus	0.00058	0.00106	CcSEcCtD
Alendronate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000576	0.00105	CcSEcCtD
Alendronate—Alopecia—Ramipril—type 2 diabetes mellitus	0.000575	0.00105	CcSEcCtD
Alendronate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000574	0.00104	CcSEcCtD
Alendronate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000574	0.00104	CcSEcCtD
Alendronate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000572	0.00104	CcSEcCtD
Alendronate—Constipation—Valsartan—type 2 diabetes mellitus	0.00057	0.00104	CcSEcCtD
Alendronate—Infection—Irbesartan—type 2 diabetes mellitus	0.000569	0.00104	CcSEcCtD
Alendronate—Erythema—Ramipril—type 2 diabetes mellitus	0.000566	0.00103	CcSEcCtD
Alendronate—Pain—Orlistat—type 2 diabetes mellitus	0.000563	0.00103	CcSEcCtD
Alendronate—Chest pain—Losartan—type 2 diabetes mellitus	0.000562	0.00102	CcSEcCtD
Alendronate—Myalgia—Losartan—type 2 diabetes mellitus	0.000562	0.00102	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.000562	0.00218	CbGpPWpGaD
Alendronate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000562	0.00102	CcSEcCtD
Alendronate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000557	0.00102	CcSEcCtD
Alendronate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000557	0.00101	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000556	0.00216	CbGpPWpGaD
Alendronate—Discomfort—Losartan—type 2 diabetes mellitus	0.000556	0.00101	CcSEcCtD
Alendronate—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000555	0.00101	CcSEcCtD
Alendronate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000554	0.00101	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000553	0.00101	CcSEcCtD
Alendronate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000553	0.00101	CcSEcCtD
Alendronate—FDPS—Metabolism—BHMT—type 2 diabetes mellitus	0.000552	0.00214	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000545	0.000993	CcSEcCtD
Alendronate—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000545	0.000992	CcSEcCtD
Alendronate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000543	0.000989	CcSEcCtD
Alendronate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000539	0.000981	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—type 2 diabetes mellitus	0.000536	0.00208	CbGpPWpGaD
Alendronate—Infection—Losartan—type 2 diabetes mellitus	0.000536	0.000976	CcSEcCtD
Alendronate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000535	0.000974	CcSEcCtD
Alendronate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000534	0.000973	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000531	0.00206	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000531	0.00206	CbGpPWpGaD
Alendronate—Urticaria—Valsartan—type 2 diabetes mellitus	0.00053	0.000965	CcSEcCtD
Alendronate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000527	0.00096	CcSEcCtD
Alendronate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000526	0.000957	CcSEcCtD
Alendronate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000525	0.000956	CcSEcCtD
Alendronate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000523	0.000953	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000522	0.000951	CcSEcCtD
Alendronate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000521	0.000948	CcSEcCtD
Alendronate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000521	0.000948	CcSEcCtD
Alendronate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000521	0.000948	CcSEcCtD
Alendronate—Constipation—Metformin—type 2 diabetes mellitus	0.000519	0.000945	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000519	0.00201	CbGpPWpGaD
Alendronate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000518	0.000943	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000516	0.002	CbGpPWpGaD
Alendronate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000514	0.000936	CcSEcCtD
Alendronate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000513	0.000935	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000513	0.00199	CbGpPWpGaD
Alendronate—Malaise—Ramipril—type 2 diabetes mellitus	0.000511	0.00093	CcSEcCtD
Alendronate—Rash—Glyburide—type 2 diabetes mellitus	0.000509	0.000928	CcSEcCtD
Alendronate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000509	0.000927	CcSEcCtD
Alendronate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000509	0.000927	CcSEcCtD
Alendronate—Headache—Glyburide—type 2 diabetes mellitus	0.000506	0.000922	CcSEcCtD
Alendronate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000504	0.000918	CcSEcCtD
Alendronate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.0005	0.000911	CcSEcCtD
Alendronate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000496	0.000904	CcSEcCtD
Alendronate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000496	0.000904	CcSEcCtD
Alendronate—ATP6V1A—Disease—ACACA—type 2 diabetes mellitus	0.000494	0.00192	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000491	0.000895	CcSEcCtD
Alendronate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000491	0.000895	CcSEcCtD
Alendronate—Constipation—Irbesartan—type 2 diabetes mellitus	0.00049	0.000892	CcSEcCtD
Alendronate—Pain—Irbesartan—type 2 diabetes mellitus	0.00049	0.000892	CcSEcCtD
Alendronate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000485	0.000884	CcSEcCtD
Alendronate—Urticaria—Metformin—type 2 diabetes mellitus	0.000482	0.000878	CcSEcCtD
Alendronate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000482	0.000878	CcSEcCtD
Alendronate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000482	0.000878	CcSEcCtD
Alendronate—FDPS—Metabolism—AANAT—type 2 diabetes mellitus	0.000482	0.00187	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGDS—type 2 diabetes mellitus	0.000482	0.00187	CbGpPWpGaD
Alendronate—Nausea—Glyburide—type 2 diabetes mellitus	0.00048	0.000874	CcSEcCtD
Alendronate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00048	0.000874	CcSEcCtD
Alendronate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00048	0.000874	CcSEcCtD
Alendronate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000478	0.000871	CcSEcCtD
Alendronate—Discomfort—Ramipril—type 2 diabetes mellitus	0.000476	0.000868	CcSEcCtD
Alendronate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000475	0.000864	CcSEcCtD
Alendronate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000473	0.000861	CcSEcCtD
Alendronate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000472	0.00086	CcSEcCtD
Alendronate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000472	0.000859	CcSEcCtD
Alendronate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000468	0.000853	CcSEcCtD
Alendronate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000466	0.000849	CcSEcCtD
Alendronate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000461	0.00084	CcSEcCtD
Alendronate—Constipation—Losartan—type 2 diabetes mellitus	0.000461	0.00084	CcSEcCtD
Alendronate—Pain—Losartan—type 2 diabetes mellitus	0.000461	0.00084	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000458	0.00178	CbGpPWpGaD
Alendronate—Rash—Gliclazide—type 2 diabetes mellitus	0.000457	0.000833	CcSEcCtD
Alendronate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000457	0.000832	CcSEcCtD
Alendronate—FDPS—Metabolism—CDO1—type 2 diabetes mellitus	0.000457	0.00177	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPD2—type 2 diabetes mellitus	0.000457	0.00177	CbGpPWpGaD
Alendronate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000456	0.000831	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000456	0.00177	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SLC5A2—type 2 diabetes mellitus	0.000455	0.00177	CbGpPWpGaD
Alendronate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000455	0.000829	CcSEcCtD
Alendronate—Headache—Gliclazide—type 2 diabetes mellitus	0.000455	0.000828	CcSEcCtD
Alendronate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000453	0.000825	CcSEcCtD
Alendronate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000453	0.000825	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000452	0.00175	CbGpPWpGaD
Alendronate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000451	0.000821	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000447	0.00173	CbGpPWpGaD
Alendronate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000444	0.000809	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000444	0.00172	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000441	0.000803	CcSEcCtD
Alendronate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000441	0.000803	CcSEcCtD
Alendronate—FDPS—Metabolism—AK1—type 2 diabetes mellitus	0.000436	0.00169	CbGpPWpGaD
Alendronate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000436	0.000793	CcSEcCtD
Alendronate—Asthenia—Metformin—type 2 diabetes mellitus	0.000436	0.000793	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000431	0.00167	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000431	0.00167	CbGpPWpGaD
Alendronate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000431	0.000785	CcSEcCtD
Alendronate—Pruritus—Metformin—type 2 diabetes mellitus	0.000429	0.000782	CcSEcCtD
Alendronate—Urticaria—Losartan—type 2 diabetes mellitus	0.000428	0.00078	CcSEcCtD
Alendronate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000426	0.000776	CcSEcCtD
Alendronate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000426	0.000776	CcSEcCtD
Alendronate—FDPS—SREBP signalling—AKT1—type 2 diabetes mellitus	0.000426	0.00165	CbGpPWpGaD
Alendronate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000424	0.000772	CcSEcCtD
Alendronate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000422	0.000769	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000421	0.000767	CcSEcCtD
Alendronate—Rash—Valsartan—type 2 diabetes mellitus	0.00042	0.000766	CcSEcCtD
Alendronate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00042	0.000765	CcSEcCtD
Alendronate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000419	0.000763	CcSEcCtD
Alendronate—Headache—Valsartan—type 2 diabetes mellitus	0.000418	0.000761	CcSEcCtD
Alendronate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000415	0.000756	CcSEcCtD
Alendronate—Rash—Orlistat—type 2 diabetes mellitus	0.000415	0.000756	CcSEcCtD
Alendronate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000415	0.000756	CcSEcCtD
Alendronate—ATP6V1A—Disease—PCK1—type 2 diabetes mellitus	0.000414	0.00161	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000413	0.0016	CbGpPWpGaD
Alendronate—Headache—Orlistat—type 2 diabetes mellitus	0.000413	0.000752	CcSEcCtD
Alendronate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000411	0.000749	CcSEcCtD
Alendronate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000407	0.000741	CcSEcCtD
Alendronate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000405	0.000738	CcSEcCtD
Alendronate—FDPS—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000402	0.00156	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MAT1A—type 2 diabetes mellitus	0.000402	0.00156	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TLE4—type 2 diabetes mellitus	0.000402	0.00156	CbGpPWpGaD
Alendronate—Dizziness—Metformin—type 2 diabetes mellitus	0.000401	0.000731	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000401	0.00156	CbGpPWpGaD
Alendronate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000397	0.000723	CcSEcCtD
Alendronate—Nausea—Valsartan—type 2 diabetes mellitus	0.000396	0.000721	CcSEcCtD
Alendronate—Constipation—Ramipril—type 2 diabetes mellitus	0.000395	0.00072	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000394	0.00153	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000393	0.00153	CbGpPWpGaD
Alendronate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000392	0.000714	CcSEcCtD
Alendronate—Nausea—Orlistat—type 2 diabetes mellitus	0.000391	0.000713	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.00039	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—G6PC—type 2 diabetes mellitus	0.000389	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ND1—type 2 diabetes mellitus	0.000389	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000389	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HBA2—type 2 diabetes mellitus	0.000389	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENPP1—type 2 diabetes mellitus	0.000389	0.00151	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HK1—type 2 diabetes mellitus	0.000387	0.0015	CbGpPWpGaD
Alendronate—Asthenia—Losartan—type 2 diabetes mellitus	0.000387	0.000705	CcSEcCtD
Alendronate—Vomiting—Metformin—type 2 diabetes mellitus	0.000386	0.000703	CcSEcCtD
Alendronate—Rash—Metformin—type 2 diabetes mellitus	0.000383	0.000697	CcSEcCtD
Alendronate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000382	0.000696	CcSEcCtD
Alendronate—Pruritus—Losartan—type 2 diabetes mellitus	0.000381	0.000695	CcSEcCtD
Alendronate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000381	0.000694	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—type 2 diabetes mellitus	0.000381	0.00148	CbGpPWpGaD
Alendronate—Headache—Metformin—type 2 diabetes mellitus	0.00038	0.000693	CcSEcCtD
Alendronate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000379	0.00069	CcSEcCtD
Alendronate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000378	0.000688	CcSEcCtD
Alendronate—FDPS—Metabolism—GCGR—type 2 diabetes mellitus	0.000376	0.00146	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GCKR—type 2 diabetes mellitus	0.000374	0.00145	CbGpPWpGaD
Alendronate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000369	0.000672	CcSEcCtD
Alendronate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000367	0.000669	CcSEcCtD
Alendronate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000365	0.000666	CcSEcCtD
Alendronate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000365	0.000666	CcSEcCtD
Alendronate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000364	0.000663	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000362	0.00141	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000362	0.00141	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000362	0.00141	CbGpPWpGaD
Alendronate—Rash—Irbesartan—type 2 diabetes mellitus	0.000361	0.000658	CcSEcCtD
Alendronate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000361	0.000657	CcSEcCtD
Alendronate—Nausea—Metformin—type 2 diabetes mellitus	0.000361	0.000657	CcSEcCtD
Alendronate—Headache—Irbesartan—type 2 diabetes mellitus	0.000359	0.000654	CcSEcCtD
Alendronate—ATP6V1A—Disease—ALDOB—type 2 diabetes mellitus	0.000359	0.00139	CbGpPWpGaD
Alendronate—Dizziness—Losartan—type 2 diabetes mellitus	0.000356	0.000649	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000356	0.00138	CbGpPWpGaD
Alendronate—FDPS—Metabolism—OXCT1—type 2 diabetes mellitus	0.000355	0.00138	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYTB—type 2 diabetes mellitus	0.000355	0.00138	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000354	0.00138	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000351	0.00136	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000346	0.00134	CbGpPWpGaD
Alendronate—Vomiting—Losartan—type 2 diabetes mellitus	0.000343	0.000624	CcSEcCtD
Alendronate—ATP6V1A—Disease—SPRY2—type 2 diabetes mellitus	0.000342	0.00133	CbGpPWpGaD
Alendronate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000341	0.00062	CcSEcCtD
Alendronate—Nausea—Irbesartan—type 2 diabetes mellitus	0.00034	0.00062	CcSEcCtD
Alendronate—Rash—Losartan—type 2 diabetes mellitus	0.00034	0.000619	CcSEcCtD
Alendronate—Dermatitis—Losartan—type 2 diabetes mellitus	0.00034	0.000619	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.00034	0.00132	CbGpPWpGaD
Alendronate—Headache—Losartan—type 2 diabetes mellitus	0.000338	0.000615	CcSEcCtD
Alendronate—ATP6V1A—Disease—RBP4—type 2 diabetes mellitus	0.000333	0.00129	CbGpPWpGaD
Alendronate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000332	0.000604	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000331	0.00129	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ACACA—type 2 diabetes mellitus	0.00033	0.00128	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD17B3—type 2 diabetes mellitus	0.00033	0.00128	CbGpPWpGaD
Alendronate—FDPS—Metabolism—STAR—type 2 diabetes mellitus	0.00033	0.00128	CbGpPWpGaD
Alendronate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000327	0.000596	CcSEcCtD
Alendronate—Nausea—Losartan—type 2 diabetes mellitus	0.00032	0.000583	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000319	0.00124	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000317	0.00123	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CBS—type 2 diabetes mellitus	0.000317	0.00123	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCC8—type 2 diabetes mellitus	0.000317	0.00123	CbGpPWpGaD
Alendronate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000316	0.000576	CcSEcCtD
Alendronate—ATP6V1A—Disease—SLC2A2—type 2 diabetes mellitus	0.000311	0.00121	CbGpPWpGaD
Alendronate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000306	0.000557	CcSEcCtD
Alendronate—FDPS—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000305	0.00118	CbGpPWpGaD
Alendronate—FDPS—Metabolism—COX2—type 2 diabetes mellitus	0.000305	0.00118	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTR—type 2 diabetes mellitus	0.000305	0.00118	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000303	0.00118	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOA6—type 2 diabetes mellitus	0.0003	0.00116	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000299	0.00116	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NAMPT—type 2 diabetes mellitus	0.000299	0.00116	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GCK—type 2 diabetes mellitus	0.000297	0.00115	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IAPP—type 2 diabetes mellitus	0.000295	0.00115	CbGpPWpGaD
Alendronate—FDPS—Metabolism—UCP3—type 2 diabetes mellitus	0.000295	0.00114	CbGpPWpGaD
Alendronate—FDPS—Metabolism—UCP2—type 2 diabetes mellitus	0.000295	0.00114	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000295	0.00114	CbGpPWpGaD
Alendronate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000294	0.000535	CcSEcCtD
Alendronate—Rash—Ramipril—type 2 diabetes mellitus	0.000291	0.000531	CcSEcCtD
Alendronate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000291	0.00053	CcSEcCtD
Alendronate—ATP6V1A—Disease—SLC9A1—type 2 diabetes mellitus	0.00029	0.00113	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.00029	0.00112	CbGpPWpGaD
Alendronate—Headache—Ramipril—type 2 diabetes mellitus	0.00029	0.000527	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000286	0.00111	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000285	0.00111	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000282	0.00109	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PCK1—type 2 diabetes mellitus	0.000277	0.00108	CbGpPWpGaD
Alendronate—Nausea—Ramipril—type 2 diabetes mellitus	0.000275	0.0005	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000273	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HMGA1—type 2 diabetes mellitus	0.000272	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000271	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000269	0.00104	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PSMD6—type 2 diabetes mellitus	0.000267	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SNAP25—type 2 diabetes mellitus	0.000267	0.00103	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000266	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000262	0.00102	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HK1—type 2 diabetes mellitus	0.000259	0.00101	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000259	0.00101	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CYBA—type 2 diabetes mellitus	0.000258	0.001	CbGpPWpGaD
Alendronate—FDPS—Metabolism—KCNJ11—type 2 diabetes mellitus	0.00025	0.000972	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LPA—type 2 diabetes mellitus	0.00025	0.000972	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD3B2—type 2 diabetes mellitus	0.00025	0.000972	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCKR—type 2 diabetes mellitus	0.00025	0.000972	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CALCA—type 2 diabetes mellitus	0.00025	0.000969	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000242	0.000939	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SLC2A1—type 2 diabetes mellitus	0.000241	0.000936	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000241	0.000935	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALDOB—type 2 diabetes mellitus	0.00024	0.000932	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.00024	0.00093	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.00024	0.00093	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS1—type 2 diabetes mellitus	0.000238	0.000922	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TCF7L2—type 2 diabetes mellitus	0.000235	0.000913	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000233	0.000906	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000233	0.000906	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000233	0.000905	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SLC2A4—type 2 diabetes mellitus	0.000231	0.000897	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.00023	0.000892	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000228	0.000887	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000226	0.000877	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GLP1R—type 2 diabetes mellitus	0.000223	0.000867	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000213	0.000826	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000208	0.000809	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000208	0.000808	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000207	0.000803	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000206	0.000798	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CPT1A—type 2 diabetes mellitus	0.000204	0.000793	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTR—type 2 diabetes mellitus	0.000204	0.000793	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000202	0.000784	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFBR2—type 2 diabetes mellitus	0.000201	0.000781	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000201	0.000779	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NAMPT—type 2 diabetes mellitus	0.0002	0.000777	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000199	0.000773	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HBA1—type 2 diabetes mellitus	0.000199	0.000772	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LIPC—type 2 diabetes mellitus	0.000199	0.000772	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCK—type 2 diabetes mellitus	0.000199	0.000772	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000198	0.000768	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN2B—type 2 diabetes mellitus	0.000195	0.000756	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000194	0.000754	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000192	0.000746	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CETP—type 2 diabetes mellitus	0.000192	0.000745	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOB—type 2 diabetes mellitus	0.00019	0.000737	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000187	0.000725	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000187	0.000725	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000182	0.000705	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LPL—type 2 diabetes mellitus	0.000181	0.000704	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000181	0.000702	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000179	0.000695	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PSMD6—type 2 diabetes mellitus	0.000178	0.000693	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SREBF1—type 2 diabetes mellitus	0.000178	0.000693	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SNAP25—type 2 diabetes mellitus	0.000178	0.000693	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000178	0.00069	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ADCY5—type 2 diabetes mellitus	0.000178	0.000689	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000177	0.000687	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000177	0.000687	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CTGF—type 2 diabetes mellitus	0.000175	0.00068	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000175	0.000679	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMGCR—type 2 diabetes mellitus	0.000174	0.000674	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000171	0.000665	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PPP2CA—type 2 diabetes mellitus	0.00017	0.000661	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ADRA2A—type 2 diabetes mellitus	0.00017	0.00066	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CCR5—type 2 diabetes mellitus	0.000167	0.000649	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000165	0.000639	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—type 2 diabetes mellitus	0.000163	0.000634	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000163	0.000634	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000162	0.000628	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000162	0.000628	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000161	0.000627	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000161	0.000627	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000159	0.000618	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000159	0.000616	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000157	0.000611	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000157	0.000608	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HIF1A—type 2 diabetes mellitus	0.000156	0.000605	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IRS2—type 2 diabetes mellitus	0.000155	0.000603	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000155	0.000601	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCG—type 2 diabetes mellitus	0.000155	0.000601	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CALM1—type 2 diabetes mellitus	0.000153	0.000592	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—type 2 diabetes mellitus	0.000152	0.00059	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOA1—type 2 diabetes mellitus	0.00015	0.000583	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—type 2 diabetes mellitus	0.000142	0.00055	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000141	0.000547	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000139	0.000542	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000138	0.000534	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000138	0.000534	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000137	0.000532	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000136	0.00053	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IRS1—type 2 diabetes mellitus	0.000136	0.000526	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GNB3—type 2 diabetes mellitus	0.000133	0.000518	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000133	0.000518	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000133	0.000516	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—type 2 diabetes mellitus	0.000133	0.000515	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000132	0.000514	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAT—type 2 diabetes mellitus	0.000131	0.000508	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000131	0.000508	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—INS—type 2 diabetes mellitus	0.00013	0.000504	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOB—type 2 diabetes mellitus	0.000127	0.000494	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000127	0.000493	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT2—type 2 diabetes mellitus	0.000125	0.000487	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000124	0.000483	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—type 2 diabetes mellitus	0.000124	0.00048	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LPL—type 2 diabetes mellitus	0.000121	0.000471	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—type 2 diabetes mellitus	0.000119	0.000463	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000119	0.000463	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ADCY5—type 2 diabetes mellitus	0.000119	0.000461	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX1—type 2 diabetes mellitus	0.000118	0.00046	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000117	0.000454	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CD36—type 2 diabetes mellitus	0.000115	0.000448	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—C3—type 2 diabetes mellitus	0.000114	0.000444	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000114	0.000442	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3R1—type 2 diabetes mellitus	0.000114	0.000442	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—type 2 diabetes mellitus	0.000114	0.000442	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—type 2 diabetes mellitus	0.000109	0.000424	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000109	0.000423	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000109	0.000422	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000109	0.000422	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARA—type 2 diabetes mellitus	0.000107	0.000416	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000107	0.000415	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000106	0.000413	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000106	0.000413	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000105	0.000409	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—type 2 diabetes mellitus	0.000104	0.000404	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AGT—type 2 diabetes mellitus	0.000104	0.000403	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CALM1—type 2 diabetes mellitus	0.000102	0.000396	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—type 2 diabetes mellitus	0.000102	0.000395	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA1—type 2 diabetes mellitus	0.000101	0.000391	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.0001	0.00039	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.49e-05	0.000369	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INS—type 2 diabetes mellitus	9.09e-05	0.000353	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.95e-05	0.000347	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—type 2 diabetes mellitus	8.86e-05	0.000344	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.79e-05	0.000341	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.79e-05	0.000341	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INS—type 2 diabetes mellitus	8.69e-05	0.000338	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—type 2 diabetes mellitus	8.42e-05	0.000327	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.35e-05	0.000324	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.97e-05	0.00031	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.97e-05	0.00031	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—type 2 diabetes mellitus	7.97e-05	0.000309	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—type 2 diabetes mellitus	7.62e-05	0.000296	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3R1—type 2 diabetes mellitus	7.62e-05	0.000296	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—type 2 diabetes mellitus	7.53e-05	0.000292	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RELA—type 2 diabetes mellitus	7.51e-05	0.000291	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—type 2 diabetes mellitus	7.38e-05	0.000287	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—type 2 diabetes mellitus	6.97e-05	0.000271	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.77e-05	0.000263	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.4e-05	0.000248	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.33e-05	0.000246	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.9e-05	0.000229	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.74e-05	0.000223	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—type 2 diabetes mellitus	5.67e-05	0.00022	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.27e-05	0.000205	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—type 2 diabetes mellitus	5.23e-05	0.000203	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.17e-05	0.000201	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.97e-05	0.000154	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.67e-05	0.000142	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—type 2 diabetes mellitus	3.5e-05	0.000136	CbGpPWpGaD
